Aggravation of exercise-induced intestinal injury by ibuprofen in athletes

Medicine and Science in Sports and Exercise

Volumn 44, Issue 12, 2012, Pages 2257-2262

  Van Wijck, Kim ^a,b   Lenaerts, Kaatje ^a,b   Van Bijnen, Annemarie A ^b   Boonen, Bas ^b   Van Loon, Luc J C ^a,b   Dejong, Cornelis H C ^a,b   Buurman, Wim A ^b  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Exercise; Gastrointestinal damage; NSAID; Permeability

Indexed keywords

BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; ATHLETE; BICYCLE; BLOOD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; INJURY; INTESTINE MUCOSA; MALE; METABOLISM; NETHERLANDS; PAIN; PERMEABILITY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SMALL INTESTINE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATHLETES; BICYCLING; BIOLOGICAL MARKERS; FATTY ACID-BINDING PROTEINS; HUMANS; IBUPROFEN; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; NETHERLANDS; PAIN; PERMEABILITY;

EID: 84870063060     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e318265dd3d     Document Type: Article

References (36)

1. Alaranta A, Alaranta H, Heliovaara M, Airaksinen M, Helenius I. Ample use of physician-prescribed medications in Finnish elite athletes. Int J Sports Med. 2006;27(11):919-25. (Pubitemid 44759327)
2. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med. 1992;327(11):749-54.
3. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology. 1995;108(5):1566-81.
4. Bjarnason I, Takeuchi K. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy. J Gastroenterol. 2009; 44(19 suppl):S23-9.
5. Blikslager AT. Life in the gut without oxygen: adaptive mechanisms and inflammatory bowel disease. Gastroenterology. 2008; 134(1):346-8. (Pubitemid 350309354)
6. Blikslager AT, Moeser AJ, Gookin JL, Jones SL, Odle J. Restoration of barrier function in injured intestinal mucosa. Physiol Rev. 2007;87(2):545-64.
7. Cheetham TC, Graham DJ, Campen D, et al. Myocardial infarction and its association with the use of nonselective NSAIDs: a nested case-control and time-To-event analysis. Perm J. 2008;12(1): 16-22.
8. Choi SC, Choi SJ, Kim JA, et al. The role of gastrointestinal endoscopy in long-distance runners with gastrointestinal symptoms. Eur J Gastroenterol Hepatol. 2001;13(9):1089-94.
9. Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol Suppl. 1997;49:15-9.
10. Derikx JP, Matthijsen RA, de Bruine AP, et al. Rapid reversal of human intestinal ischemia-reperfusion induced damage by shedding of injured enterocytes and reepithelialisation. PLoS One. 2008;3(10):e3428.
11. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs. A meta-Analysis. Ann Intern Med. 1991; 115(10):787-96.
12. Garcia Rodriguez LA, Barreales Tolosa L. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology. 2007; 132(2):498-506.
13. Garcia Rodriguez LA, Gonzalez-Perez A, Bueno H, Hwa J. NSAID use selectively increases the risk of non-fatal myocardial infarction: a systematic review of randomised trials and observational studies. PLoS One. 2011;6(2):e16780.
14. Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994;343(8900):769-72.
15. Garcin M, Mille-Hamard L, Billat V, Imbenotte M, Humbert L, Lhermitte Z. Use of acetaminophen in young subelite athletes. J Sports Med Phys Fitness. 2005;45(4):604-7.
16. Gorski T, Cadore EL, Pinto SS, et al. Use of NSAIDs in triathletes: prevalence, level of awareness and reasons for use. Br J Sports Med. 2011;45(2):85-90.
17. Graham DJ, Campen D, Hui R, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclooxygenase 2 selective and non-selective non-steroidal antiinflammatory drugs: nested case-control study. Lancet. 2005; 365(9458):475-81.
18. Kuipers H, Verstappen FT, Keizer HA, Geurten P, van Kranenburg G. Variability of aerobic performance in the laboratory and its physiologic correlates. Int J Sports Med. 1985;6(4):197-201.
19. Lieberman JM, Sacchettini J, Marks C, Marks WH. Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia. Surgery. 1997; 121(3):335-42.
20. Martin MJ, Jimenez MD, Motilva V. New issues about nitric oxide and its effects on the gastrointestinal tract. Curr Pharm Des. 2001;7(10):881-908.
21. Matsui H, Shimokawa O, Kaneko T, Nagano Y, Rai K, Hyodo I. The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestine. J Clin Biochem Nutr. 2011;48(2):107-11.
22. Ng SC, Chan FK. NSAID-induced gastrointestinal and cardiovascular injury. Curr Opin Gastroenterol. 2010;26(6):611-7.
23. Oktedalen O, Lunde OC, Opstad PK, Aabakken L, Kvernebo K. Changes in the gastrointestinal mucosa after long-distance running. Scand J Gastroenterol. 1992;27(4):270-4.
24. Otte JA, Oostveen E, Geelkerken RH, Groeneveld AB, Kolkman JJ. Exercise induces gastric ischemia in healthy volunteers: a tonometry study. J Appl Physiol. 2001;91(2):866-71.
25. Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta. 2005; 352(1-2):15-35.
26. Peters HP, Bos M, Seebregts L, et al. Gastrointestinal symptoms in long-distance runners, cyclists, and triathletes: prevalence, medication, and etiology. Am J Gastroenterol. 1999;94(6):1570-81.
27. Qamar MI, Read AE. Effects of exercise on mesenteric blood flow in man. Gut. 1987;28(5):583-7. (Pubitemid 17073225)
28. Rainsford KD. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology. 2009;17(6):275-342.
29. Taioli E. Use of permitted drugs in Italian professional soccer players. Br J Sports Med. 2007;41(7):439-41.
30. Takeuchi K, Tanaka A, Kato S, Amagase K, Satoh H. Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. Clin Chim Acta. 2010;411(7-8):459-66.
31. ter Steege RW, Van der Palen J, Kolkman JJ. Prevalence of gastrointestinal complaints in runners competing in a long-distance run: an internet-based observational study in 1281 subjects. Scand J Gastroenterol. 2008;43(12):1477-82.
32. Thuyne WV, Delbeke FT. Declared use of medication in sports. Clin J Sport Med. 2008;18(2):143-7. (Pubitemid 351365720)
33. van Wijck K, Lenaerts K, van Loon LJ, Peters WH, Buurman WA, Dejong CH. Exercise-induced splanchnic hypoperfusion results in gut dysfunction in healthy men. PLoS One. 2011;6(7):e22366.
34. van Wijck K, van Eijk HM, Buurman WA, Dejong CH, Lenaerts K. Novel analytical approach to a multi-sugar whole gut permeability assay. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879(26):2794-801.
35. Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself? Physiol Rev. 2008; 88(4):1547-65.
36. Watanabe T, Higuchi K, Kobata A, et al. Non-steroidal antiinflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut. 2008;57(2):181-7. (Pubitemid 351158044)